A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Debut Biotech, a company innovating new molecules through advanced biotechnology, is partnering with Image Skincare to launch ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

California VC firm Aditum Bio is at it again, this time partnering up with China-based Mabwell Bioscience to launch a new biotech focused on cardiovascular disease. Aditum has paid Mabwell $12 million ...

New Wave Biotech has launched a new Life Cycle Assessment (LCA) tool tailored to the biotechnology sector, designed to provide real-time visibility into the ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...

Hood College has announced a new biotechnology training program that was launched using a nearly $1 million federal grant. The Innovative, Immersive Training Program in Synthetic Biology and ...